NICE Says Sequential Use Of TNF Inhibitors To Treat RA Is Not Cost Effective
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency, however, recommends use of Abbott's Humira, Wyeth's Enbrel and Johnson & Johnson's Remicade to treat RA.